397 related articles for article (PubMed ID: 14665610)
1. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
2. Economics of preoperative radiotherapy with total mesorectal excision: what can we learn from the Dutch experience?
Simunovic M; Gafni A; Levine M
J Clin Oncol; 2004 Jan; 22(2):217-9. PubMed ID: 14665616
[No Abstract] [Full Text] [Related]
3. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
4. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
5. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
6. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
[TBL] [Abstract][Full Text] [Related]
7. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
Kapiteijn E; Kranenbarg EK; Steup WH; Taat CW; Rutten HJ; Wiggers T; van Krieken JH; Hermans J; Leer JW; van de Velde CJ
Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155
[TBL] [Abstract][Full Text] [Related]
8. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis.
Neuman HB; Elkin EB; Guillem JG; Paty PB; Weiser MR; Wong WD; Temple LK
Dis Colon Rectum; 2009 May; 52(5):863-71. PubMed ID: 19502849
[TBL] [Abstract][Full Text] [Related]
9. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction.
Rinfret S; Cohen DJ; Lamas GA; Fleischmann KE; Weinstein MC; Orav J; Schron E; Lee KL; Goldman L
Circulation; 2005 Jan; 111(2):165-72. PubMed ID: 15630030
[TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
13. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
[TBL] [Abstract][Full Text] [Related]
15. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
16. Impact of radiotherapy on local recurrence of rectal cancer in Norway.
Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B;
Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
18. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.
Marijnen CA; van de Velde CJ; Putter H; van den Brink M; Maas CP; Martijn H; Rutten HJ; Wiggers T; Kranenbarg EK; Leer JW; Stiggelbout AM
J Clin Oncol; 2005 Mar; 23(9):1847-58. PubMed ID: 15774778
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
